Synthesis and preliminary evaluation of a novel glutamine derivative: (2S,4S)4-[18F]FEBGln

Add time:08/26/2019    Source:sciencedirect.com

We report the preparation of a novel glutamine derivative, (2S,4S)-2,5-diamino-4-(4-(2-fluoroethoxy)benzyl)-5-oxopentanoic acid, (2S, 4S)4-[18F]FEBGln ([18F]4), through efficient organic and radiosyntheses. In vitro assays of [18F]4 using MCF-7 cells showed that it entered cells via multiple amino acid transporter systems including system L and ASC2 transporters but not through the system A transporter. [18F]4 showed promising properties for tumor imaging and may serve as a lead compound for further optimizing and targeting the system L transporter associated with enhanced glutamine metabolism in cancer cells.

We also recommend Trading Suppliers and Manufacturers of (-)-N-[[(2S)-1-Ethyl-2-pyrrolidinyl]methyl]-2-hydroxy-3-iodo-6-methoxybenzamide (cas 113716-48-6). Pls Click Website Link as below: cas 113716-48-6 suppliers

Prev:Brief communicationPru du 2S albumin or Pru du vicilin?
Next:Beyond nPDFs effects: Prompt J/ψ and ψ(2S) production in pPb and pp collisions)